0001126234-22-000053.txt : 20220509 0001126234-22-000053.hdr.sgml : 20220509 20220509170911 ACCESSION NUMBER: 0001126234-22-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220505 FILED AS OF DATE: 20220509 DATE AS OF CHANGE: 20220509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON CHAD ALLEN CENTRAL INDEX KEY: 0001734108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35342 FILM NUMBER: 22906085 MAIL ADDRESS: STREET 1: C/O NEWLINK GENETICS CORPORATION STREET 2: 2503 SOUTH LOOP DRIVE CITY: AMES STATE: IA ZIP: 50010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LUMOS PHARMA, INC. CENTRAL INDEX KEY: 0001126234 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421491350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 BUSINESS PHONE: 512-215-2630 MAIL ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 FORMER COMPANY: FORMER CONFORMED NAME: NEWLINK GENETICS CORP DATE OF NAME CHANGE: 20001012 4 1 wf-form4_165213053735609.xml FORM 4 X0306 4 2022-05-05 0 0001126234 LUMOS PHARMA, INC. (LUMO) 0001734108 JOHNSON CHAD ALLEN 4200 MARATHON BLVD SUITE 200 AUSTIN TX 78756 1 0 0 0 Stock Option (Right to Buy) 8.18 2022-05-05 4 A 0 3431 0 A 2032-05-04 Common Stock 3431.0 3431 D Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant. /s/ Ryan Trytten, attorney-in-fact 2022-05-09